Central Pacific Bank - Trust Division’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Buy
1,805
+5
+0.3% +$259 0.01% 561
2026
Q1
$91.4K Buy
+1,800
New +$84K 0.01% 593

Other funds holding MRNA

Central Pacific Bank - Trust Division's MRNA Position: Q2 2026 in Review

Central Pacific Bank - Trust Division increased its Moderna (MRNA) stake by 0.28% in Q2 2026, buying an estimated $259 and bringing the position to 1,805 shares worth $126K. The position accounts for 0.01% of the portfolio, ranked #561.

Central Pacific Bank - Trust Division first reported a position in MRNA in Q1 2026 and has held it in 2 quarters since. 435 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Central Pacific Bank - Trust Division held 1,805 shares of Moderna worth $126K as of Q2 2026.
  • Central Pacific Bank - Trust Division bought 5 Moderna shares in Q2 2026, an estimated $259.
  • Moderna made up 0.01% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #561 holding.
  • Central Pacific Bank - Trust Division first reported a position in Moderna in Q1 2026 and has held it in 2 quarters since.
  • 435 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.